New Therapies Support
Endometriosis Drug Development
PartnershipsActive
Key Facts
About Endodiag
Endodiag is a pioneering diagnostics company dedicated to transforming the endometriosis care pathway. The company is developing a multi-pronged approach, including a first-of-its-kind blood test for early diagnosis, a solution for mapping the disease to guide surgical and therapeutic decisions, and leveraging its biomarker expertise to support novel drug development. Operating in a field with major diagnostic delays and no cure, Endodiag targets a large, underserved patient population (affecting ~10% of women) with solutions intended for healthcare professionals. Its work has been recognized through nominations for industry awards like the Galien Medstartup prize.
View full company profile